background
clostridium
difficil
carriag
consid
potenti
sourc
deadli
infect
role
cancer
patient
still
unclear
aim
identifi
clinic
immunolog
factor
relat
c
difficil
carriag
chines
cancer
patient
method
total
stool
sampl
collect
cancer
patient
receiv
chemotherapi
three
hospit
eastern
china
bacteri
genom
dna
extract
two
toxin
gene
tcda
tcdb
detect
pcr
ribotyp
perform
use
capillari
gel
electrophoresi
concentr
prostaglandin
transform
growth
factor
beta
measur
use
enzymelink
immunosorb
assay
elisa
kit
result
eightytwo
sampl
confirm
c
difficileposit
posit
tpi
tcda
tcdb
gene
c
difficileposit
rate
patient
diarrhea
diarrhea
respect
p
patient
younger
year
old
hospit
least
day
c
difficileposit
rate
high
contrast
patient
older
year
old
hospit
less
day
c
difficileposit
rate
p
associ
found
c
difficil
carriag
chemotherapi
regimen
antibiot
drug
use
immunosuppress
mediat
prostaglandin
transform
growth
factor
beta
twelv
ribotyp
c
difficil
identifi
none
belong
ribotyp
conclus
conclud
younger
patient
longer
hospit
stay
may
prone
c
difficil
carriag
studi
larger
popul
warrant
clarifi
exact
role
c
difficil
carriag
hospit
cancer
patient
china
clostridium
difficil
infect
hospitalacquir
infect
preval
increas
accord
report
us
center
diseas
control
prevent
c
difficil
infect
consid
urgent
threat
requir
immedi
attent
major
risk
factor
c
difficil
infect
includ
use
antibiot
use
proton
pump
inhibitor
ppi
hospit
age
condit
may
affect
colon
flora
report
cancer
patient
higher
risk
c
difficil
infect
compar
noncanc
patient
howev
inform
current
avail
c
difficil
infect
nononcolog
popul
still
lack
comprehens
epidemiolog
studi
c
difficil
infect
china
let
alon
specif
investig
cancer
popul
herein
conduct
comprehens
investig
c
difficil
carriag
cancer
patient
three
hospit
eastern
china
hope
identifi
potenti
clinic
laboratori
factor
relat
c
difficil
carriag
varieti
cancer
patient
sampl
collect
cancer
center
three
hospit
first
affili
hospit
zhejiang
univers
yuyao
hospit
huzhou
central
hospit
center
sixti
bed
expect
admit
cancer
patient
total
per
year
patient
provid
written
consent
studi
protocol
approv
institut
ethic
committe
three
hospit
sampl
collect
first
stool
sampl
admiss
collect
cancer
patient
inform
collect
patient
includ
follow
time
sampl
collect
age
gender
diagnosi
gastroenterolog
surgeri
within
last
month
cumul
day
hospit
within
last
month
chemotherapi
regimen
antibiot
drug
use
within
last
month
ppi
use
diarrhea
within
last
month
well
count
white
blood
cell
blood
albumin
medic
record
review
patient
interview
conduct
assess
diarrhea
symptom
diarrhea
defin
three
loos
wateri
stool
passag
period
diarrhea
classifi
follow
mild
diarrhea
character
absenc
sign
symptom
coliti
moder
diarrhea
character
presenc
coliti
fever
abdomin
cramp
usual
lower
quadrant
sever
diarrhea
defin
coliti
associ
leukocyt
count
greater
equal
cellsl
serum
creatinin
level
greater
equal
time
premorbid
level
stool
specimen
treat
alcohol
mixtur
inocul
cefoxitincycloserin
fructos
agar
ccfa
plate
oxoid
basingstok
incub
h
genbag
anaerob
chamber
marci
letoil
franc
isol
confirm
c
difficil
base
assay
previous
describ
bacteri
genom
dna
extract
use
dna
extract
kit
qiagen
inc
valencia
ca
accord
manufactur
instruct
housekeep
gene
tpi
two
toxin
gene
tcda
b
detect
use
assay
previous
describ
amplifi
product
analyz
electrophoresi
ethidium
bromid
dna
sequenc
polymeras
chain
reaction
pcr
product
perform
accord
standard
protocol
pcr
ribotyp
perform
use
capillari
gel
electrophoresi
primer
pair
describ
previous
size
peak
determin
use
genemapp
idx
softwar
appli
biosystem
capillari
sequencerbas
pcrribotyp
data
analyz
use
webribo
websit
http
webriboagesat
concentr
prostaglandin
maibio
shanghai
china
transform
growth
factor
beta
ebiosci
san
diego
ca
usa
ebiosci
san
diego
ca
usa
measur
use
enzymelink
immunosorb
assay
elisa
kit
elisa
kit
purchas
compani
respect
elisa
carri
accord
manufactur
instruct
statist
analysi
perform
spss
chicago
il
usa
first
r
c
conting
tabl
establish
consolid
quantit
data
data
divid
differ
group
chisquar
test
use
analyz
categor
data
ftest
ttest
conduct
hetero
equal
varianc
analysi
signific
variabl
determin
univari
cox
regress
analysi
figur
statist
signific
test
defin
p
total
sampl
collect
april
octob
number
sampl
obtain
zhejiang
univers
yuyao
huzhou
hospit
respect
male
femal
patient
median
age
year
old
characterist
patient
c
difficil
detect
outcom
list
tabl
among
c
difficileposit
patient
tcda
tcdb
posit
strain
tcda
tcdb
toxin
genedelet
strain
tcda
tcdb
tcdaand
tcdb
identifi
diarrheal
patient
consid
mild
diarrhea
moder
sever
diarrhea
identifi
c
difficileposit
rate
diarrhea
nondiarrhea
patient
respect
p
shown
tabl
associ
found
c
difficileposit
rate
clinic
factor
includ
collect
time
sex
diagnosi
ppi
use
chemotherapi
regimen
gastroenterolog
surgeri
within
last
month
antibiot
drug
use
within
last
month
mean
age
c
difficileposit
c
difficileneg
patient
year
old
respect
ttest
show
c
difficil
infect
rate
two
group
significantli
differ
p
next
patient
divid
five
consecut
age
group
shown
figur
cancer
patient
two
age
group
patient
younger
year
old
higher
infect
rate
three
group
patient
older
year
old
therefor
year
old
set
cutoff
valu
patient
group
two
group
base
age
infect
rate
younger
group
older
group
differ
statist
signific
x
p
cumul
day
hospit
c
difficil
carriag
rate
next
determin
cumul
number
day
hospit
relat
c
difficil
posit
rate
c
difficileneg
patient
cumul
number
day
hospit
within
month
sampl
collect
day
c
difficileposit
patient
cumul
number
day
hospit
day
significantli
longer
p
analysi
show
differ
signific
patient
divid
two
group
hospit
day
longer
less
day
c
difficileposit
rate
respect
x
p
day
hospit
set
cutoff
valu
cancer
patient
combin
age
day
hospit
c
difficileposit
rate
use
two
cutoff
valu
year
old
day
hospit
cancer
patient
divid
four
group
posit
rate
c
difficil
variou
group
analyz
shown
figur
posit
rate
high
patient
younger
year
old
hospit
least
day
contrast
posit
rate
patient
older
year
old
hospit
less
day
differ
highli
signific
x
p
ribotyp
c
difficil
sampl
determin
result
yield
ribotyp
pattern
includ
ribotyp
n
ribotyp
n
ribotyp
n
ribotyp
n
ribotyp
n
one
ribotyp
none
strain
belong
ribotyp
immunolog
indic
c
difficileposit
rate
albumin
level
white
blood
cell
count
concentr
import
immunolog
indic
cancer
patient
indic
test
associ
c
difficil
carriag
b
subdivis
c
difficil
posit
rate
age
day
hospit
note
patient
organ
two
age
group
cutoff
valu
year
old
age
group
subdivid
two
group
base
number
day
hospit
day
day
c
difficil
posit
rate
significantli
differ
group
year
old
hospit
day
compar
group
year
old
hospit
day
vs
p
factor
includ
white
blood
cell
count
albumin
count
concentr
significantli
differ
c
difficileposit
neg
patient
studi
conduct
comprehens
investig
c
difficil
carriag
among
cancer
patient
three
hospit
eastern
china
overal
c
difficileposit
rate
cancer
patient
enrol
period
rate
much
higher
report
noncanc
patient
similar
studi
eastern
china
relationship
variou
clinic
immunolog
factor
c
difficil
carriag
analyz
two
factor
age
day
hospit
determin
significantli
associ
rate
c
difficil
carriag
first
found
cancer
patient
c
difficil
carriag
appear
younger
patient
us
differ
could
caus
variou
factor
diet
geograph
locat
intak
food
supplement
drug
caus
studi
also
found
featur
gut
microbiom
alway
uniqu
differ
locat
lifestyl
lifestyl
chines
peopl
especi
young
chines
chang
dramat
last
year
partial
rapid
growth
chines
economi
chang
lifestyl
common
china
past
might
major
contributor
increas
emerg
c
difficil
infect
interestingli
age
predisposit
consist
previou
studi
cancer
patient
beij
china
meanwhil
larg
scale
studi
japan
also
reveal
long
hospit
stay
associ
c
difficil
infect
howev
two
studi
provid
cutoff
valu
age
hospit
day
studi
found
cancer
patient
younger
year
old
stay
hospit
day
prone
c
difficil
carriag
easier
understand
longer
stay
hospit
expos
higher
risk
infect
patient
less
clear
us
younger
patient
studi
prone
c
difficil
carriag
similar
result
report
recent
northern
china
immun
respons
import
c
difficil
carriag
howev
among
white
blood
cell
count
albumin
count
level
thought
inhibitor
immunolog
activ
found
factor
relat
c
difficileposit
rate
ribotyp
c
difficil
show
strain
major
caus
deadli
c
difficil
infect
emerg
canada
strikingli
c
difficileposit
cancer
patient
studi
symptom
diarrhea
reason
might
complic
similar
studi
also
show
outbreak
c
difficil
infect
despit
c
difficil
carriag
nevertheless
research
suggest
asymptomat
carrier
contribut
c
difficil
transmiss
hospit
result
nearindefinit
viabil
bacteria
low
infect
dose
c
difficil
could
wide
transmit
within
hospit
presenc
ever
increas
asymptomat
carrier
current
studi
cancerspecif
factor
identifi
relat
c
difficil
carriag
howev
younger
age
longer
hospit
stay
may
repres
characterist
aggress
immunosuppress
oncolog
diseas
larger
sampl
size
cancerspecif
inform
mine
research
need
futur
order
clarifi
exact
role
c
difficil
carriag
cancer
patient
